UCB Visited by Chinese Authorities Amid Glaxo Probe

UCB SA’s Chinese operations were visited by local authorities following the government’s probe of GlaxoSmithKline Plc over allegations of economic crimes.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.